C4 Therapeutics, Inc.CCCCNASDAQ
LOADING
|||
Price to Sales: Discounted Valuation
Trending lower, below historical average, structural decline.
Left:
||||
Price-to-sales ratio
Latest
7.02
↓ 72% below average
Average (6y)
25.12
Historical baseline
Range
High:51.25
Low:7.02
CAGR
-15.6%
Structural decline
| Period | Value | Change |
|---|---|---|
| 2024 | 7.02 | -48.1% |
| 2023 | 13.51 | +45.8% |
| 2022 | 9.27 | -71.4% |
| 2021 | 32.38 | -24.7% |
| 2020 | 42.98 | -16.1% |
| 2019 | 51.25 | +163.3% |
| 2018 | 19.47 | - |